Figure 3From: Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancerKaplan-Meier curve of matched patient series. P = 0.008. Herceptin™ therapy (n = 48) compared with conventionally treated HER2 positive (n = 4) and conventionally treated HER2 negative (n = 16) patients. CT = conventional therapy; HER = human epidermal growth factor receptor; HT = Herceptin™ therapy.Back to article page